Literature DB >> 8083907

Antithrombin III and trauma patients: factors that determine low levels.

R S Miller1, D A Weatherford, D Stein, M M Crane, M Stein.   

Abstract

A prospective (cohort) study was conducted to determine the incidence of low antithrombin III (AT III) levels and the association with selected clinical variables in adult trauma patients. One hundred sixty AT III levels were obtained on 50 consecutive trauma admissions to a community-based level I trauma center. Antithrombin III levels were drawn as soon after admission as possible and every other day thereafter. Thirty-one patients (62%) had at least one low AT III level (< 80%), whereas 15 concurrently drawn control levels were all > or = 90%. Low AT III levels were more common in patients with one or more of the following: base deficit less than -4 (39% vs. 0, p = 0.002); Injury Severity Score > 15 (48% vs. 16%, p = 0.04); and blood transfusion (32% vs. 5%, p = 0.04). All other variables (shock, surgical intervention, subcutaneous heparin, and sequential compression devices) were not statistically significant, although all six patients with shock had low levels. In conclusion, over 60% of adult trauma patients had low AT III levels at some time during hospitalization and these patients were clearly more severely injured. Further studies are required to determine if these patients are more susceptible to thromboembolic phenomena.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083907

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Characterization of distinct coagulopathic phenotypes in injury: Pathway-specific drivers and implications for individualized treatment.

Authors:  S Ariane Christie; Lucy Z Kornblith; Benjamin M Howard; Amanda S Conroy; Ryan C Kunitake; Mary F Nelson; Carolyn M Hendrickson; Carolyn S Calfee; Rachael A Callcut; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

2.  Risk of postoperative venous thromboembolism in Indian patients sustaining pelvi-acetabular injury.

Authors:  Ramesh Kumar Sen; Amit Kumar; Sujit Kumar Tripathy; Sameer Aggarwal; N Khandelwal; Sakthivel R R Manoharan
Journal:  Int Orthop       Date:  2010-07-24       Impact factor: 3.075

3.  Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial.

Authors:  Molly Elizabeth Droege; Christopher Allen Droege; Carolyn Dosen Philpott; Megan Leslie Webb; Neil Edward Ernst; Krishna Athota; Devin Wakefield; Joseph Richard Dowd; Dina Gomaa; Bryce H R Robinson; Dennis Hanseman; Joel Elterman; Eric William Mueller
Journal:  J Thromb Thrombolysis       Date:  2021-05-12       Impact factor: 2.300

4.  Is routine thromboprophylaxis justified among Indian patients sustaining major orthopedic trauma? A systematic review.

Authors:  Ramesh K Sen; Sujit K Tripathy; Amit K Singh
Journal:  Indian J Orthop       Date:  2011-05       Impact factor: 1.251

Review 5.  Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.

Authors:  Satoshi Gando; Yasuhiro Otomo
Journal:  Crit Care       Date:  2015-02-23       Impact factor: 9.097

6.  Acute venous thromboembolism in Indian patients of isolated proximal femur fractures.

Authors:  Rahul Saket; Sameer Aggarwal; Vishal Kumar; Prasoon Kumar; Sandeep Patel
Journal:  J Clin Orthop Trauma       Date:  2019-02-27

7.  Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study.

Authors:  Hironori Matsumoto; Jun Takeba; Kensuke Umakoshi; Satoshi Kikuchi; Muneaki Ohshita; Suguru Annen; Naoki Moriyama; Yuki Nakabayashi; Norio Sato; Mayuki Aibiki
Journal:  Thromb J       Date:  2018-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.